All Vaccinology articles – Page 19
-
NewsResearchers on cusp of a new vaccine modality breakthrough
Researchers have succeeded in developing a new vaccine modality that is a stable particulate vaccine. The new vaccine modality is at proof-of-concept stage and in early development.
-
-
NewsBooster shot being developed to fight koala Chlamydia
Researchers are developing a booster vaccine using implant technology in the fight against the deadly Chlamydia disease that has decimated koala colonies.
-
NewsNew VDEC is ‘step change’ for UK’s growing vaccine capabilities
The UK Health Security Agency has unveiled its world-leading Vaccine Development and Evaluation Centre at Porton Down, which will be at the forefront of the UK’s ability to develop vaccines against the world’s deadliest pathogens.
-
OpinionNew RSV vaccines on the way - so what do we do about vaccine hesitancy?
Not one, but two promising new vaccines are likely to be introduced to the UK, yet routine childhood vaccination rates have been decreasing for ‘old’ diseases like measles and polio - what’s going on?
-
NewsModerna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
NewsCOVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
-
NewsNewly discovered antibodies can neutralize COVID-19 variants
Scientists have isolated potent neutralizing antibodies from a COVID-19 vaccinated SARS survivor that exhibited remarkable breadth against known sarbecoviruses.
-
NewsScientists develop new solid-state storage method for biological materials
Scientists have developed a novel method for storing biological materials such as RNA and proteins in a solid-state, physically resembling a pill or a tablet, which dissolves in water for on-demand use.
-
NewsSpike protein mutants with low binding affinity usher in new Covid vaccine
Researchers have succeeded in producing a new vaccine against the SARS-CoV-2 coronavirus by identifying spike protein mutants that lack binding affinity.
-
-
NewsBreakthrough harnesses mRNA technology to develop malaria vaccine
A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year, yet has no effective long-lasting vaccine.
-
NewsNew MenB vaccine heralds use of genetic vaccines to combat bacterial diseases
A vaccine candidate that can protect children from Meningococcal group B (MenB), which can lead to meningitis, has progressed to clinical development, researchers say.
-
NewsPartnership to use AI to speed up vaccine development against Disease X
CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats.
-
NewsNew cholera substrains in Bangladesh uncovered by genomic surveillance
Researchers have uncovered two new cholera substrains in a displaced refugee population in southern Bangladesh, where a pre-emptive mass vaccination campaign of over one million refugees was successful in preventing an epidemic.
-
NewsFiji launches mass vaccination campaign against typhoid
The Ministry of Health and Medical Services (MHMS) of Fiji has launched a mass vaccination campaign against typhoid in the Northern Division, aiming to immunize the entire population between 9 months and 65 years of age.
-
NewsPurecap technique opens doors to more effective mRNA vaccines
Researchers have developed a method to produce highly active mRNA vaccines at high purity using a unique cap to easily separate the desired capped mRNA.
-
NewsCOVID-19 jab reduced disease disparities between low- and high-income communities
COVID-19 vaccination helped reduce disparities in disease incidence between low- and high-income communities, according to a new analysis led by Cedars-Sinai investigators.
-
NewsNanoparticle may improve mRNA cancer vaccines
Tests in mice with melanoma and colon cancer show the tiny particle creates an ‘army’ of immune cells that carry vaccine’s instructions, say the researchers.
-
NewsVaccine will protect farmed crocodiles from West Nile virus
A University of Queensland developed vaccine will protect farmed saltwater crocodiles from West Nile virus (WNV), providing economic and biodiversity benefits to northern Australia.